LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation-Reference-Cited by-同舟云学术

LEAM vs. BEAM vs. CLV Conditioning Regimen for Autologous Stem Cell Transplantation in Malignant Lymphomas. Retrospective Comparison of Toxicity and Efficacy on 222 Patients in the First 100 Days After Transplant, On Behalf of the Romanian Society for Bone Marrow Transplantation

Published:2019-09-10 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Colita Andrei,Colita Anca,Bumbea Horia,Croitoru Adina,Orban Carmen,Lipan Lavinia Eugenia,Craciun Oana-Gabriela,Soare Dan,Ghimici Cecilia,Manolache Raluca,Gelatu Ionel,Vladareanu Ana-Maria,Pasca Sergiu,Teodorescu Patric,Dima Delia,Lupu Anca,Coriu Daniel,Tomuleasa Ciprian,Tanase Alina

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference40 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin.,2019

2. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med.,2002

3. Outcomes of haploidentical stem cell transplantation for lymphoma with melphalan-based conditioning;Brammer;Biol Blood Marrow Transplant.,2016

4. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation;Gaballa;Cancer.,2016

5. A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM;Kothari;Bone Marrow Transplant.,2016

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifteen year Follow-up of Relapsed/ Refractory Patients with Hodgkin Lymphoma Treated with Autologous Hematopoietic Stem Cell Transplantation;Journal of Stem Cell Therapy and Transplantation;2024-07-02

2. Cisplatin as a Viable and Secure Alternative to Carmustine in BEAM-Based Conditioning for Autologous Hematopoietic Stem Cell Transplantation in Patients with Lymphoma;Transplantation Proceedings;2024-07

3. CEAC (oral semustine, etoposide, cytarabine and cyclophosphamide) vs BEAM (carmustine, etoposide, cytarabine, and melphalan) conditioning regimen of autologous stem cell transplantation for diffuse large B-cell lymphoma: a post-hoc, propensity score-matched, cohort study in Chinese patients;Annals of Hematology;2023-11-06

4. Age, CD34+ cell dose, conditioning and pre‐transplant cytopenias can help predict transfusion support in lymphoma patients undergoing autologous stem cell transplantation;Vox Sanguinis;2023-06-25

5. Stem Cell Transplant for Hodgkin Lymphoma;Basics of Hematopoietic Stem Cell Transplant;2023